The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J01 | Antibacterials for systemic use | |
| 3 | J01X | Other antibacterials | |
| 4 | J01XA | Glycopeptide antibacterials | |
| 5 | J01XA05 |
| Active Ingredient | Description | |
|---|---|---|
| Oritavancin |
Oritavancin is used for the treatment of patients with acute bacterial skin and skin structure infections (ABSSSI). |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ORBACTIV Powder for solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| TENKASI Powder for solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
